Uncategorized

Samsara Vision to Initiate a U.S. PMA Supplemental Study of the SING IMT™, a New-Generation Technology for Age-Related Macular Degeneration

by Business Wire • 2022/04/20 • 0 Comments

FAR HILLS, N.J.--(BUSINESS WIRE)-- #AMD--Samsara Vision to Initiate a U.S. PMA Supplemental Study of the SING IMT™, a New-Generation Technology for Age-Related Macular Degeneration

Full Story →

← Aerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting →

Post navigation